These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses. Wildner O; Morris JC J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429 [TBL] [Abstract][Full Text] [Related]
4. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Lambright ES; Amin K; Wiewrodt R; Force SD; Lanuti M; Propert KJ; Litzky L; Kaiser LR; Albelda SM Gene Ther; 2001 Jun; 8(12):946-53. PubMed ID: 11426335 [TBL] [Abstract][Full Text] [Related]
5. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer. Wildner O; Morris JC; Vahanian NN; Ford H; Ramsey WJ; Blaese RM Gene Ther; 1999 Jan; 6(1):57-62. PubMed ID: 10341876 [TBL] [Abstract][Full Text] [Related]
6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
7. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase. Wei SJ; Chao Y; Hung YM; Lin WC; Yang DM; Shih YL; Ch'ang LY; Whang-Peng J; Yang WK Exp Cell Res; 1998 May; 241(1):66-75. PubMed ID: 9633514 [TBL] [Abstract][Full Text] [Related]
8. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment. Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218 [TBL] [Abstract][Full Text] [Related]
10. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model. Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705 [TBL] [Abstract][Full Text] [Related]
13. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models. Mizuno M; Ryuke Y; Yoshida J Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023 [TBL] [Abstract][Full Text] [Related]
14. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer. Rancourt C; Bergeron C; Lane D; Garon G; Piché A Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047 [TBL] [Abstract][Full Text] [Related]
15. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice. Kanazawa T; Mizukami H; Okada T; Hanazono Y; Kume A; Nishino H; Takeuchi K; Kitamura K; Ichimura K; Ozawa K Gene Ther; 2003 Jan; 10(1):51-8. PubMed ID: 12525837 [TBL] [Abstract][Full Text] [Related]
16. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Wildner O; Hoffmann D; Jogler C; Uberla K Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232 [TBL] [Abstract][Full Text] [Related]
17. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium]. Wang B; Weng J Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913 [TBL] [Abstract][Full Text] [Related]
18. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer. Kagaya T; Nakamoto Y; Sakai Y; Tsuchiyama T; Yagita H; Mukaida N; Kaneko S Cancer Gene Ther; 2006 Apr; 13(4):357-66. PubMed ID: 16224495 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer. Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003 [TBL] [Abstract][Full Text] [Related]
20. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo. Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]